Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Biogen Surrenders All Early Gains After Q2 Beat And Raise

Courtesy of Benzinga.

Biogen Inc (NASDAQ: BIIB) shares are trading lower by $2.00 at $282.70 in Tuesday’s session.

The stock in the red despite posting a Q2 EPS beat of 63 cents along with a $17 million beat for sales. The company significantly raised FY 2017 EPS and sales guidance.

After a higher open, Biogen continued in that direction before finally peaking at $291.91 and reversing course. The ensuing decline has found support in a familiar area. Over its previous five sessions, it has bottomed in the $280.00 handle, between $280.01 and $280.75 and today’s low stands at $280.24 as of 12:30 p.m. EST.

The rebound off that low peaked at $287.56 and is now drifting back towards the low for the session.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!